You are here

Human herpesvirus 8 infection and Kaposi's sarcoma among human immunodeficiency virus-infected and -uninfected women.

TitleHuman herpesvirus 8 infection and Kaposi's sarcoma among human immunodeficiency virus-infected and -uninfected women.
Publication TypeJournal Article
Year of Publication2001
AuthorsGreenblatt, RM, Jacobson, LP, Levine, AM, Melnick, S, Anastos, K, Cohen, M, DeHovitz, J, Young, MA, Burns, D, Miotti, P, Koelle, DM
JournalJ Infect Dis
Volume183
Issue7
Pagination1130-4
Date Published2001 Apr 1
ISSN0022-1899
KeywordsAdult, Antibodies, Viral, California, Cocaine, Cohort Studies, Crack Cocaine, Cross-Sectional Studies, District of Columbia, Female, Heroin, Herpesviridae Infections, Herpesvirus 8, Human, HIV Infections, HIV Seronegativity, HIV Seropositivity, Humans, New York, Prevalence, Risk Factors, Sarcoma, Kaposi, Seroepidemiologic Studies, Sex Factors, Substance Abuse, Intravenous, Syphilis
Abstract

Little is known about the epidemiology of human herpesvirus 8 (HHV-8) infections among women. A cross-sectional study was conducted of HHV-8 infection among human immunodeficiency virus (HIV)-infected and high-risk HIV-uninfected women. Serological tests with noninduced (latent) and induced (lytic) HHV-8 antigens were used to detect infection among 2483 participants of a multisite cohort. Reactivity to latent antigen was present in 4.1% and to induced antigens in 12.0% of women. Seven of 8 women who reported Kaposi's sarcoma had HHV-8 antibodies. Among HIV-positive women, HHV-8 infection was associated with use of crack, cocaine, or heroin (76% vs. 65%; P<.001), past syphilis (29% vs. 20%; P<.001), an injection drug-using male sex partner (61% vs. 53%; P=.014), black race (P=.010), and enrollment site (P=.015). In multivariate analysis, HIV infection, older age, past syphilis, black race, and enrollment site were independently associated with HHV-8 infection. In this cohort of North American women, HHV-8 infection was associated with HIV infection, drug use, and risky sexual behavior.

DOI10.1086/319270
Alternate JournalJ. Infect. Dis.
PubMed ID11237842